Literature DB >> 9848031

Assessment of HIV risk.

M C Chawarski1, J Pakes, R S Schottenfeld.   

Abstract

Based on the review of existing instruments and analysis of problems encountered in clinical and research practice with one of the most commonly used assessment instruments, the RAB, this paper proposes a number of solutions aimed at improving validity, and efficiency of assessment of HIV risk in drug abusing populations. Briefly, five domains of assessment are discussed: intravenous drug use, high-risk sexual behaviors, knowledge of HIV transmission and methods of prevention, psychological aspects of behavioral change, and epidemiological factors of HIV transmission. The paper discusses also changes in format, scope, and context, as well as scoring procedures that may improve discriminability and sensitivity to detect change of a comprehensive HIV risk assessment instrument. Finally, a process of developing an HIV risk assessment instrument, the ARI-I, which is based on the proposed recommendations and which incorporates methodological improvements discussed in the paper is briefly described.

Entities:  

Mesh:

Year:  1998        PMID: 9848031     DOI: 10.1300/J069v17n04_05

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  11 in total

1.  Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness.

Authors:  Stanley D Rosenberg; Richard W Goldberg; Lisa B Dixon; George L Wolford; Eric P Slade; Seth Himelhoch; Gerard Gallucci; Wendy Potts; Stephanie Tapscott; Christopher J Welsh
Journal:  Psychiatr Serv       Date:  2010-09       Impact factor: 3.084

2.  SCREENING FOR AND PREVALENCE OF HIV AND HEPATITIS C AMONG AN OUTPATIENT URBAN SAMPLE OF PEOPLE WITH SERIOUS MENTAL ILLNESS AND CO-OCCURRING SUBSTANCE ABUSE.

Authors:  Seth Himelhoch; Richard Goldberg; Christine Calmes; Deborah Medoff; Eric Slade; Lisa Dixon; Gerard Gallucci; Stanley Rosenberg
Journal:  J Community Psychol       Date:  2011-02-02

3.  Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.

Authors:  Kim T Mueser; Anne G Crocker; Linda B Frisman; Robert E Drake; Nancy H Covell; Susan M Essock
Journal:  Schizophr Bull       Date:  2006-03-30       Impact factor: 9.306

4.  Application of the social action theory to understand factors associated with risky sexual behavior among individuals in residential substance abuse treatment.

Authors:  Elizabeth K Reynolds; Jessica F Magidson; Marina A Bornovalova; Marya Gwadz; Craig K Ewart; Stacey B Daughters; C W Lejuez
Journal:  Psychol Addict Behav       Date:  2010-06

5.  "Shotgunning" in a population of patients with severe mental illness and comorbid substance use disorders.

Authors:  Christopher Welsh; Richard Goldberg; Stephanie Tapscott; Deborah Medoff; Stanley Rosenberg; Lisa Dixon
Journal:  Am J Addict       Date:  2012 Mar-Apr

6.  Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

Authors:  S D Rosenberg; L A Goodman; F C Osher; M S Swartz; S M Essock; M I Butterfield; N T Constantine; G L Wolford; M P Salyers
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.

Authors:  M C Chawarski; W Zhou; R S Schottenfeld
Journal:  Drug Alcohol Depend       Date:  2010-12-14       Impact factor: 4.492

8.  Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot study.

Authors:  B L Norton; M A Bachhuber; R Singh; L Agyemang; J H Arnsten; C O Cunningham; A H Litwin
Journal:  Int J Drug Policy       Date:  2019-04-16

9.  Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness.

Authors:  Marian I Butterfield; Hayden B Bosworth; Karen M Stechuchak; Richard Frothingham; Lori A Bastian; Keith G Meador; Marvin Swartz; Ron D Horner
Journal:  J Natl Med Assoc       Date:  2004-01       Impact factor: 1.798

10.  Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Authors:  Lynn E Sullivan; Brent A Moore; Marek C Chawarski; Michael V Pantalon; Declan Barry; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2007-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.